Immunohistochemistry (Figure 5B, Supplementary Table S4 and Supplementary Figure S2) shows the levels of p-STAT3 in the bladder cancer animal model treated with metformin are consistently lower. Here, STAT3 is linked to urinary bladder carcinoma.